# Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT

> **NCT05011149** · PHASE3 · RECRUITING · sponsor: **IWK Health Centre** · enrollment: 100 (estimated)

## Conditions studied

- Patent Ductus Arteriosus After Premature Birth

## Interventions

- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT05011149
- **Lead sponsor:** IWK Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-10
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05011149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05011149, "Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05011149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*